Sartorius Stedim Biotech SA (DIM)

DIM · Health Care · France

Sartorius Stedim Biotech SA (DIM) is a company in the Health Care sector, based in France. The stock is held in 26 ETFs we track – with its largest weight of 0.09 % in XD5E (msci-emu). Anyone holding one of these ETFs also owns a small indirect stake in Sartorius Stedim Biotech.

Very high ETF coverage: 26 of the 95 ETFs we cover hold Sartorius Stedim Biotech, spread across 9 indices. That puts the stock in more ETFs than 95.3 % of the 4,334 stocks we cover.

Held in26 ETFs

Highest weight0.09 %

Indices9

SectorHealth Care

CountryFrance

ISINFR0013154002

Data note 1

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XD5E	msci-emu	0.09 %	€0.90
XEMU	msci-emu	0.09 %	€0.90
ZPRE	msci-emu	0.08 %	€0.80
XDWH	msci-world-health-care	0.08 %	€0.80
SPFS	msci-world-health-care	0.08 %	€0.80
IMEA	msci-europe	0.05 %	€0.50
XMEU / XIEE	msci-europe	0.05 %	€0.50
EXSA	stoxx-600	0.04 %	€0.40
X600 / XESU	stoxx-600	0.04 %	€0.40
SPYE	msci-europe	0.04 %	€0.40
XSX6 / XSX7	stoxx-600	0.04 %	€0.40
EXUS / EXU1	msci-world-ex-usa	0.03 %	€0.30
SWWD	msci-world	0.01 %	€0.10
WIMI	msci-world-imi	0.01 %	€0.10
SPYY	msci-acwi	0.01 %	€0.10
EUNL	msci-world	0.01 %	€0.10
IUSQ	msci-acwi	0.01 %	€0.10
SPPW	msci-world	0.01 %	€0.10
XDWD / XDWL	msci-world	0.01 %	€0.10
SPYI / SPSA	msci-acwi-imi	0.00 %	€0.00

Data note 2

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Sartorius Stedim Biotech as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, Sartorius Stedim Biotech had a weight of 0.01 % on Sep 30, 2019 and 0.01 % on Sep 16, 2026. Its share peaked at 0.03 % on Sep 30, 2021. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 3

How much Sartorius Stedim Biotech SA overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.